Advertisement

Scalp Mesotherapy

  • Renan Minotto
  • Rodrigo Vettorato
Chapter
  • 17 Downloads

Abstract

Hair mesotherapy is useful for some scalp diseases. In general reaches good clinical outcomes when conducted by expert dermatologists. Hair mesotherapy is used as an adjunct to conventional treatments for some scalp diseases. As a monotherapy, however, it is indicated when there are contraindications for the well-established treatments or unresponsiveness to them. In general, scalp mesotherapy reaches good clinical outcomes when conducted by an expert professional on that technique.

Keywords

Hair mesotherapy Hair intradermal therapy Lebel needle Growth factors Cocktails 

References

  1. 1.
    Kutlubay Z, Karakus Ö. Hair mesotherapy. Hair Ther Transplant. 2012;2:1–3.CrossRefGoogle Scholar
  2. 2.
    Moftah N, Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B, Ibrahim M. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol. 2013;27:686–93.  https://doi.org/10.1111/j.1468-3083.2012.04535.CrossRefPubMedGoogle Scholar
  3. 3.
    Abdallah M, El-Zawahry K, Besar H. Mesotherapy using dutasteride-containing solution in male pattern hair loss: a controlled pilot study. PALD. 2009;20:137–45.Google Scholar
  4. 4.
    Sobhy N, Aly H, Shafee AE, Deeb MA. Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males. Our Dermatol Online. 2013;4:40–5.CrossRefGoogle Scholar
  5. 5.
    Azam MH, Morsi HM. Comparative study between 2% minoxidil topical spray vs. intradermal injection (mesotherapy) for treatment of androgenetic alopecia in female patients: a controlled, 4-month randomized trial. EDOJ. 2010;6:1–12.Google Scholar
  6. 6.
    Chandrashekar BS, Sandeep MA, Vasanth V, Jagadish P, Rajashekar ML. Triamcinolone acetonide mesotherapy in the treatment of recalcitrant patches of alopecia areata – a pilot study. J Clin Dermatol Ther. 2015;2:006.Google Scholar
  7. 7.
    Konda D, Thappa DM. Mesotherapy: what is new? Indian J Dermatol Venereol Leprol. 2013;79:127–34.CrossRefGoogle Scholar
  8. 8.
    Herreros FOC, Moraes AM, Velho PENF. Mesoterapia: uma revisão bibliográfica. An Bras Dermatol. 2011;86(1):96–101.CrossRefGoogle Scholar
  9. 9.
    Sañudo A, Vallejo F, Sierra M, Hoyos JG, Yepes S, Wolff JC, et al. Nontuberculous mycobacteria infection after mesotherapy: preliminary report of 15 cases. Int J Dermatol. 2007;46:649–53.CrossRefGoogle Scholar
  10. 10.
    Marco-Bonnet J, Beylot-Barry M, Texier-Maugein J, Barucq JP, Supply P, Doutre MS, Beylot C. Mycobacterial bovis BCG cutaneous infections following mesotherapy: 2 cases. Ann Dermatol Venereol. 2002;129:728–31.PubMedGoogle Scholar
  11. 11.
    Kadry R, Hamadah I, Al-Issa A, Field L, Alrabiah F. Multifocal scalp abscess with sub-cutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol. 2008;7:72–3.PubMedGoogle Scholar
  12. 12.
    Gungor S, Kocaturk E, Topal IO. Frontal edema due to topical application of %5 minoxidil solution following mesotherapy injections. Int J Trichol. 2015;7:86–7.  https://doi.org/10.4103/0974-7753.160124.CrossRefGoogle Scholar
  13. 13.
    Duque-estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol. 2009;61:707–9.  https://doi.org/10.1016/j.jaad.2008.11.896.CrossRefPubMedGoogle Scholar
  14. 14.
    EL-Komy MHM, Hassan AS, Tawdy AM, Solimon MM, Hady MA. Hair loss at injection sites of mesotherapy for alopecia. J Cosmet Dermatol. 2017;16:e28–30.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Renan Minotto
    • 1
  • Rodrigo Vettorato
    • 2
  1. 1.Dermatology DepartmentUFCSPA, Hospital Santa Casa de Porto AlegrePorto AlegreBrazil
  2. 2.Department of DermatologySanta Casa HospitalPorto AlegreBrazil

Personalised recommendations